🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Lupus Erythematosus, Systemic

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site📍 Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 cell Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease NCT06497387EARLY Phase 11 site📍 Wuhan Tongji Hospital · Tests: PRG-1801 BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy Deciphering the Genetic Architecture of Autoimmune Diseases NCT06948110n/a2 sites📍 Bethesda📍 Lima National Human Genome Research Institute (NHGRI) A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases NCT06980597Phase 12 sites📍 Beijing📍 Beijing Beijing GoBroad Hospital · Tests: OL-108 " TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus NCT07397728n/a1 site📍 Qina South Valley University · Tests: TREX1 gene polymorphisms Anifrolumab Malignancy and Serious Infections Study NCT07000110n/a4 sites📍 Copenhagen📍 Charenton-le-Pont📍 Essen AstraZeneca · Tests: Anifrolumab CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythematosus NCT07855302Phase 11 site📍 Seoul Seoul National University Hospital · Tests: SNUH-CD19-CAR-T Cells, Lymphodepleting Chemotherapy CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: UCAR T-cell NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care NCT07424261n/a21 sites📍 Altenburg📍 Bad Bramstedt📍 Bamberg AstraZeneca Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment NCT07102030n/a1 site📍 Stockholm Region Stockholm A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants NCT05039619Phase 244 sites📍 Loma Linda📍 San Francisco📍 Aurora Hoffmann-La Roche · Tests: Obinutuzumab, Placebo, Mycophenolate Mofetil, Acetaminophen/paracetamol, Diphenhydramine hydrochloride (HCl) A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants NCT06576271Phase 128 sites📍 Scottsdale📍 Aurora📍 Las Vegas GlaxoSmithKline · Tests: GSK4527363, Placebo matching GSK4527363, Belimumab Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions NCT04833465n/a1 site📍 Washington D.C. Children's National Research Institute · Tests: No Intervention Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) NCT01802034n/a1 site📍 New York The Rogosin Institute HLA Antibodies in Systemic Lupus Erythematosus NCT06921239n/a1 site📍 Amiens Centre Hospitalier Universitaire, Amiens Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF NCT04702256Phase 31 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Obinutuzumab administration, Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil, Administration … A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE) NCT07311200Phase 21 site📍 Linfen InventisBio Co., Ltd · Tests: D-2570, D-2570 Placebo KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis NCT03929887n/a6 sites📍 Chuncheon📍 Daegu📍 Seoul Seoul National University Hospital · Tests: Kidney Biopsy A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) NCT06557265Phase 1, Phase 219 sites📍 Little Rock📍 Tustin📍 Gainesville Nkarta, Inc. · Tests: NKX019, Fludarabine, Cyclophosphamide Safety Study of CC312 in Autoimmune Disease Patients NCT06888960EARLY Phase 11 site📍 Tianjin CytoCares Inc · Tests: CC312 A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus. NCT06182969Phase 1, Phase 21 site📍 Shanghai Ascentage Pharma Group Inc. · Tests: APG-2575, Placebo Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects. NCT06657703Phase 13 sites📍 Beijing📍 Beijing📍 Beijing HC Biopharma Inc. · Tests: HC022, Placebo To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis NCT07629583Phase 12 sites📍 Toulouse📍 Seville Genentech, Inc. · Tests: Cevostamab, Tocilizumab Systemic Lupus Erythematosus and Accelerated Aging NCT05698173NA1 site📍 Bordeaux University Hospital, Bordeaux · Tests: blood sample, blood sample Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus NCT06585514Phase 1, Phase 21 site📍 Beijing Beijing GoBroad Hospital · Tests: CD19 CAR-T cells A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus NCT07339332EARLY Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: CAR-T Therapy Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases NCT06842316n/a1 site📍 Orléans Centre Hospitalier Régional d'Orléans · Tests: 1 blood sample, 40 mL (collection during a blood test, part of the standard of care for this disease) A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus NCT06106906Phase 1, Phase 21 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: CD19 CAR-T cell infusion Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders NCT06434363Phase 1, Phase 22 sites📍 Houston📍 Houston M.D. Anderson Cancer Center · Tests: Tafasitamab, Fludarabine phosphate, Cyclophosphamide, Tafasitamab and NK cells
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy